VIA
TARS icon

Virtus Investment Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History

Virtus Investment Advisers’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
18,771
+8,393
+81% +$536K 0.28% 184
2026
Q1 		$728K Buy
10,378
+1,979
+24% +$138K 0.2% 173
2025
Q4 		$688K Sell
8,399
-2,453
-23% -$183K 0.19% 175
2025
Q3 		$645K Hold
10,852
– – 0.18% 182
2025
Q2 		$440K Buy
10,852
+3,827
+54% +$172K 0.15% 207
2025
Q1 		$361K Buy
+7,025
New +$347K 0.1% 222

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtus Investment Advisers's TARS Position: Q2 2026 in Review

Virtus Investment Advisers increased its Tarsus Pharmaceuticals (TARS) stake by 81% in Q2 2026, buying an estimated $536K and bringing the position to 18,771 shares worth $1.18M. The position accounts for 0.28% of the portfolio, ranked #184.

Virtus Investment Advisers first reported a position in TARS in Q1 2025 and has held it in 6 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Virtus Investment Advisers held 18,771 shares of Tarsus Pharmaceuticals worth $1.18M as of Q2 2026.
  • Virtus Investment Advisers bought 8,393 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $536K.
  • Tarsus Pharmaceuticals made up 0.28% of Virtus Investment Advisers's portfolio in Q2 2026, its #184 holding.
  • Virtus Investment Advisers first reported a position in Tarsus Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.